Advertisement |
|
Q2 Solutions can enhance your precision medicine efforts by providing comprehensive genomic and biomarker discovery and development expertise, scientific acumen, data informatics and clinical trial operational excellence. Let our experience and insights help you avoid obstacles and optimize your path to developing new personalized medicines and companion diagnostics. | | | |
|
|
TABLE OF CONTENTS |
August 2015 Volume 33, Issue 8 |
| | |
| Editorial News Bioentrepreneur Opinion and Comment Features News and Views Computational Biology Research Careers and Recruitment
| |
|
|
|
|
Advertisement |
|
|
|
|
Advertisement |
|
Noncoding RNAs in Endocrinology
Noncoding RNAs have important roles in the development and regulation of the endocrine system. This web collection on noncoding RNAs in endocrinology highlights current and future applications of noncoding RNAs as diagnostic and prognostic biomarkers and as therapeutic targets for personalized management of patients with a wide range of endocrine diseases.
Access the collection online. | | | |
|
|
Editorial | Top |
|
|
|
Old boy biotech p781 doi:10.1038/nbt.3308 No matter where you look in biopharmaceutical boardrooms, gender bias is evident. Is it so difficult to actually acknowledge this pernicious bias and actively discourage all-male boards?
|
|
News | Top |
|
|
|
'Financial toxicity' looms as cancer combinations proliferate pp783 - 784 Chris Morrison doi:10.1038/nbt0815-783
|
|
|
|
New class PCSK9 blockers stride into cholesterol market pp785 - 786 Cormac Sheridan doi:10.1038/nbt0815-785
|
|
|
|
Microbial cocktails join fecal transplants in IBD treatment trials pp787 - 788 Mark Ratner doi:10.1038/nbt0815-787
|
|
|
|
Blockbuster expectations for hepatitis B therapeutic vaccine p789 Suzanne Elvidge doi:10.1038/nbt0815-789
|
|
|
|
NCI-MATCH pairs tumor mutations with matching drugs pp790 - 791 Vicki Brower doi:10.1038/nbt0815-790
|
|
|
|
Alnylam, Dicerna tussle over RNAi tech p791 doi:10.1038/nbt0815-791a
|
|
|
|
Court invalidates Sequenom's prenatal test patent p791 doi:10.1038/nbt0815-791b
|
|
|
|
PureTech floats away p792 doi:10.1038/nbt0815-792a
|
|
|
|
BGI goes head-to-head with Illumina p792 doi:10.1038/nbt0815-792b
|
|
|
|
Oxitec trials GM sterile moth to combat agricultural infestations pp792 - 793 Emily Waltz doi:10.1038/nbt0815-792c
|
|
|
|
Around the world in a month p793 doi:10.1038/nbt0815-793
|
|
|
|
Data Page |
|
|
|
2Q15—Running of the biotech bulls p794 Walter Yang doi:10.1038/nbt.3311
|
|
|
|
Drug pipeline: 2Q15 p795 Laura DeFrancesco doi:10.1038/nbt.3312
|
|
|
|
News Feature |
|
|
|
To share is human pp796 - 800 doi:10.1038/nbt.3309 Personal health data are beginning to be shared in the digital world—on mobile devices and the internet. Is the loss of privacy a price worth paying for the presumed benefits? Laura DeFrancesco investigates.
|
|
Advertisement |
Simple, Rapid, Reproducible Collection of Plasma Offering significant advantages for use with LC-MS/MS instruments, Shimadzu's Noviplex Cards allow for rapid collection of a volumetric sample of plasma (2.5 µL) from an unmeasured amount of whole blood (20 to 75 µL) within minutes. They can be used as a single step, solid-phase method for sample preparation and analyte extraction. Learn more. | | |
|
Bioentrepreneur | Top |
|
|
|
Building a business |
|
|
|
In house expertise pp801 - 804 Orin Herskowitz doi:10.1038/nbt.3302
|
|
|
|
First Rounders Podcast p804 Rachel King doi:10.1038/nbt0815-804
|
|
Opinion and Comment | Top |
|
|
|
Correspondence |
|
|
|
Flexible guide-RNA design for CRISPR applications using Protospacer Workbench pp805 - 806 Cameron Ross MacPherson and Artur Scherf doi:10.1038/nbt.3291
|
|
|
|
Health ROI as a measure of misalignment of biomedical needs and resources pp807 - 811 Lixia Yao, Ying Li, Soumitra Ghosh, James A Evans and Andrey Rzhetsky doi:10.1038/nbt.3276
|
|
|
|
Benchmarking the scientific output of the Innovative Medicines Initiative pp811 - 812 Magda Gunn, Mark Lim, Didi Cross and Michel Goldman doi:10.1038/nbt.3305
|
|
|
|
What does the current biotech stock market value? pp813 - 814 Laura McNamee and Fred Ledley doi:10.1038/nbt.3303
|
|
|
|
Commentary |
|
|
|
The smart and gentle microscope pp815 - 818 Nico Scherf and Jan Huisken doi:10.1038/nbt.3310 New instruments are needed to realize the potential of quantitative and systematic imaging of living samples. But what would such a microscope look like?
|
|
Features | Top |
|
|
|
Patents |
|
|
|
The emergence of agbiogenerics pp819 - 823 David J Jefferson, Gregory D Graff, Cecilia L Chi-Ham and Alan B Bennett doi:10.1038/nbt.3306 Although the first major agbiotech product patent has expired, regulatory requirements could continue to allot a significant degree of control to the original right holder.
|
|
|
|
Recent patents and applications in optogenetics p824 doi:10.1038/nbt.3324
|
|
News and Views | Top |
|
|
|
|
|
Computational Biology | Top |
|
|
|
Analysis |
|
|
|
Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning pp831 - 838 Babak Alipanahi, Andrew Delong, Matthew T Weirauch and Brendan J Frey doi:10.1038/nbt.3300 The binding specificities of RNA- and DNA-binding proteins are determined from experimental data using a /`deep learning/' approach.
See also: News and Views by Park & Kellis
|
|
Research | Top |
|
|
|
Brief Communications |
|
|
|
Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery pp839 - 841 Liliana Wroblewska, Tasuku Kitada, Kei Endo, Velia Siciliano, Breanna Stillo et al. doi:10.1038/nbt.3301 Using RNA-binding proteins to build genetic circuits enables RNA-only synthetic biology.
|
|
|
|
Engineered CHO cells for production of diverse, homogeneous glycoproteins pp842 - 844 Zhang Yang, Shengjun Wang, Adnan Halim, Morten Alder Schulz, Morten Frodin et al. doi:10.1038/nbt.3280 A knockout study of all human glycosyltransferases encoded in CHO cells provides a guide to producing proteins with desired glycosylation patterns.
|
|
|
|
Articles |
|
|
|
Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation pp845 - 852 Fotios Sampaziotis, Miguel Cardoso de Brito, Pedro Madrigal, Alessandro Bertero, Kourosh Saeb-Parsy et al. doi:10.1038/nbt.3275 A protocol for generating biliary epithelial cells from human pluripotent stem cells facilitates disease modeling and drug screening.
|
|
|
|
Directed differentiation of cholangiocytes from human pluripotent stem cells pp853 - 861 Mina Ogawa, Shinichiro Ogawa, Christine E Bear, Saumel Ahmadi, Stephanie Chin et al. doi:10.1038/nbt.3294 A protocol for generating biliary epithelial cells from human pluripotent stem cells facilitates disease modeling and drug screening.
|
|
|
|
Expression of trehalose-6-phosphate phosphatase in maize ears improves yield in well-watered and drought conditions pp862 - 869 Michael L Nuccio, Jeff Wu, Ron Mowers, Hua-Ping Zhou, Moez Meghji et al. doi:10.1038/nbt.3277 Expression of a single trehalose transgene in maize improves yield in field trials in both well-watered and drought conditions.
See also: News and Views by Guan & Koch
|
|
|
|
Letters |
|
|
|
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown pp870 - 876 Anders Wittrup, Angela Ai, Xing Liu, Peter Hamar, Radiana Trifonova et al. doi:10.1038/nbt.3298 Live-cell imaging provides new insights in the cytosolic release mechanismsof lipid-formulated siRNAs.
|
|
|
|
High-throughput sequencing of DNA G-quadruplex structures in the human genome pp877 - 881 Vicki S Chambers, Giovanni Marsico, Jonathan M Boutell, Marco Di Antonio, Geoffrey P Smith et al. doi:10.1038/nbt.3295 G-quadruplex structures are detected across the human genome using a high-throughput sequencing-based approach.
|
|
|
|
Corrigenda |
|
|
|
Corrigendum: Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells p882 Weida Li, Claudia Cavelti-Weder, Yinying Zhang, Kendell Clement, Scott Donovan et al. doi:10.1038/nbt0815-882a
|
|
|
|
Corrigendum: The ethics of publishing human germline research p882 Arun Sharma and Christopher Thomas Scott doi:10.1038/nbt0815-882b
|
|
|
|
Corrigendum: Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun p882 Roger G Fahmy, Alla Waldman, Guishui Zhang, Ainslie Mitchell, Nicodemus Tedla et al. doi:10.1038/nbt0815-882c
|
|
|
|
Errata |
|
|
|
Erratum: A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides p882 Joel M Chick, Deepak Kolippakkam, David P Nusinow, Bo Zhai, Ramin Rad et al. doi:10.1038/nbt0815-882d
|
|
|
|
Erratum: Public biotech 2013—the numbers p882 Stacy Lawrence and Riku Lahteenmaki doi:10.1038/nbt0815-882e
|
|
Careers and Recruitment | Top |
|
|
|
Second-quarter biotech job picture p883 Michael Francisco doi:10.1038/nbt.3314
|
|
|
|
People |
|
|
|
People p884 doi:10.1038/nbt.3320
|
|
Advertisement |
|
Nature Genetics in association with the Wellcome Trust present: THE GENOMICS OF COMMON DISEASES 2015 September 2-5, 2015 | Cambridge, UK REGISTER NOW! | | | |
|
|
| | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | |
|
|
No comments:
Post a Comment